Status
Conditions
Treatments
About
The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects must meet all of the following inclusion criteria to be enrolled in the study:
Exclusion criteria
Subjects with any of the following criteria will not be enrolled in this study:
500 participants in 1 patient group
Loading...
Central trial contact
Zhao Wei, Ph.D
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal